Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

381 evidences · page 4 / 16

15,68 scorePost-intervention mean BSE practice scores in the modern method group increased to 15.68 ± 3.12.

Nigeriacancer du seinpublié 2024BMC cancerPubMeddocument de 11 observations

7,25 %Middle-aged individuals had 7.25% knowledge about antibiotics as a breast cancer risk factor.

Nigeriacancer du seinpublié 2024JCO global oncologyPubMeddocument de 12 observations

5,2 %Luminal B subtype was found in 5.2% of cases.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations

1,9 %Medullary carcinoma accounted for 14 (1.9%) of the 761 breast cancer patients.

Nigeriacancer du sein · medullary carcinomaobservé 2008 to 2012publié 2019The Pan African medical journalPubMeddocument de 7 observations

0,036 p_valueTP53 was significantly associated with breast cancer (five cases, zero controls; P = .036).

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

49 %Among 436 treatment-naïve Nigerian breast cancer patients, 49% were classified as having low tumor-infiltrating lymphocytes (TILs) (< 10%).

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 14 observations

67,2 %In the MEND case-control study, 67.2% of Nigerian breast cancer cases were grade 2.

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 10 observations

65 %Fatigue was reported by 65% of breast cancer patients undergoing chemotherapy in Delta State, Nigeria.

Nigeriacancer du sein · fatiguepublié 2026The Pan African medical journalPubMeddocument de 5 observations

12 %Other drugs contributed 12% of the total costs for breast cancer care.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

Serum adiponectin and HDL levels were lower (p < 0.05) in the breast cancer patients relative to control subjects.

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

1,6 score_unitsThe clinical management module showed a mean knowledge score change of 1.6 (95% CI, 1.2 to 2.1) among Nigerian health care providers.

Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 5 observations

43,6 %At a median follow-up period of 20.5 months, the overall survival among patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018 was 43.6% (95% CI: 37.7 to 49.5).

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

76,2 %Seventy-six point two percent of the participants reported financial hardship as a result of breast cancer treatment costs.

Nigeriacancer du seinpublié 2023African journal of reproductive healthPubMeddocument de 4 observations

6,44 scorePre-intervention mean BSE practice scores in the modern method group were 6.44 ± 2.75.

Nigeriacancer du seinpublié 2024BMC cancerPubMeddocument de 11 observations

1 686 individualsA total of 1686 women were included in the main analyses, of whom 996 were cases and 690 were controls.

Nigeriacancer du seinpublié 2025JAMA network openPubMeddocument de 6 observations

14 %Cost precluded surgery in 14% of patients with resectable disease.

Nigeriacancer du seinpublié 2022The Pan African medical journalPubMeddocument de 9 observations

31,8 scoreThe pre-intervention overall symptom domain score was 31.8 ± 10.89 for the intervention group.

Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

74,4 %Sixty-one (74.4%) of the 82 breast cancer patients were locally advanced at presentation.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

10,5 yearsIndigenous African patients in Nigeria had a 10.5-year younger age at diagnosis of breast cancer compared to The Cancer Genome Atlas cohort.

Nigeriacancer du seinpublié 2020Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatieurope_pmcdocument de 2 observationsDOI 10.1101/2020.10.28.359240

51,2 scoreThe post-intervention overall generic functional domain score was 51.2 ± 17.8 for the control group.

Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

7 %Surgery contributed 7% of the total costs for breast cancer care.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

17 992 USDAmong 130 breast cancer patients who underwent multiple treatment modalities, the average out-of-pocket cost was $17992.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

1,9 %1.9% of the respondents had good knowledge of the risk factors and symptoms of breast cancer.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 7 observations

56,76 %Benign lesions were predominant (56.76%) among the 3,263 breast histopathology records.

Nigeriacancer du seinobservé 2015 to 2023publié 2025Scientific reportsPubMeddocument de 12 observations

49 yearsThe average age of patients with histologically confirmed breast cancer was 49 years.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 13 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.